You're viewing a public preview of Asklepion - Liquid Formulation Of Ursodeoxycholic Acid Sign up free to access full investment history, financials, executives & more

Asklepion - Liquid Formulation Of Ursodeoxycholic Acid

Inactive
United States
Sector: Life Science Entity: Private
Merged Asklepion - Liquid Formulation Of Ursodeoxycholic Acid merged into Retrophin, Inc. in 2016
2
Transactions
Sign up to view
About Asklepion - Liquid Formulation Of Ursodeoxycholic Acid
According to available private market data, Asklepion - Liquid Formulation Of Ursodeoxycholic Acid operates in the Life Science sector. Private market activity associated with the company includes investment from Retrophin, Inc.. The company is headquartered in United States. This profile is documented within Acquity Data.
Investors
Current Investors
Retrophin, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Asklepion - Liquid Formulation Of Ursodeoxycholic Acid M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Frequently Asked Questions
What does Asklepion - Liquid Formulation Of Ursodeoxycholic Acid do?
According to available private market data, Asklepion - Liquid Formulation Of Ursodeoxycholic Acid operates in the Life Science sector. Private market activity associated with the company includes investment from Retrophin, Inc.. The company is headquartered in United States. This profile is documen
Where is Asklepion - Liquid Formulation Of Ursodeoxycholic Acid headquartered?
Asklepion - Liquid Formulation Of Ursodeoxycholic Acid is headquartered in United States.
When was Asklepion - Liquid Formulation Of Ursodeoxycholic Acid founded?
Founded year information for Asklepion - Liquid Formulation Of Ursodeoxycholic Acid is available on AcquityData.
What sector is Asklepion - Liquid Formulation Of Ursodeoxycholic Acid in?
Asklepion - Liquid Formulation Of Ursodeoxycholic Acid operates in the Life Science sector.
Who are the investors in Asklepion - Liquid Formulation Of Ursodeoxycholic Acid?
Current investors in Asklepion - Liquid Formulation Of Ursodeoxycholic Acid include Retrophin, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Asklepion - Liquid Formulation Of Ursodeoxycholic Acid been involved in?
Asklepion - Liquid Formulation Of Ursodeoxycholic Acid has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Asklepion - Liquid Formulation Of Ursodeoxycholic Acid profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Asklepion - Liquid Formulation Of Ursodeoxycholic Acid's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial